| Sr.No | API Name | CAS No. | Th. Category |
| 1 | Lenalidomide | 191732-72-6 | multiple myeloma and myelodysplastic syndromes |
| 2 | Pemetrexed Disodium | 150399-23-8 | pleural mesothelioma and non-small cell lung cancer. |
| 3 | Dacarbazine | melanoma and Hodgkin’s lymphoma | |
| 4 | Hydroxy Urea | 127-07-1 | sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera |
| 5 | Thioguanine | 154-42-7 | acute myeloid leukemia, acute lymphocytic leukemia, and chronic myeloid leukemia |
| 6 | Bortezomib | 179324-69-7 | treat multiple myeloma and mantle cell lymphoma. |
| 7 | Anastrazole | 120511-73-1 | Breast cancer |
| 8 | Capacitabine | 154361-50-9 | Breast cancer, gastric cancer and colorectal cancer |
| 9 | Gemicitabine | 95058-81-4 | Breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer |
| 10 | Decitabine | 2353-33-5 | Acute myeloid leukemia (AML) |
| 11 | Cladribine | 4291-63-8 | Hairy cell leukemia |
| 12 | Lapatinib | 231277-92-2 388082-78-8 | Breast cancer and other solid tumors |
| 13 | Afatinib | 850140-72-6 | Non-small cell lung carcinoma |
| 14 | Axitinib | 319460-85-0 | Renal cell carcinoma |
| 15 | Dasatinib monohydrate | 863127-77-9 | Chronic myelogenous leukemia |
| 16 | Methotrexate | 59-05-2 | Chemotherapy agent and immune system suppressant |
| 17 | Nilotinib | 641571-10-0 | Chronic myelogenous leukemia |
| 18 | Idelalisib | 870281-82-6 | Blood cancers |
| 19 | Pazopanib | 444731-52-6 | Chemotherapy agent and immune system suppressant |
| 20 | Topotecan | 123948-87-8 119413-54-6 | Chemotherapy agent |
